Women Veterans' Substance Abuse Treatment

VA Office of Research and Development

Status

Completed

Conditions

Substance Use Disorders

Treatments

Behavioral: 12-Step Facilitation

Behavioral: A Woman's Path to Recovery

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT00734903

NEUA-001-08S

Details and patient eligibility

About

The purpose of this study is to examine the efficacy of a gender-focused addiction treatment model (A Woman's Path to Recovery) versus a non-gender focused addiction treatment model (12-Step Facilitation) in a sample of women Veterans with substance use disorder.

Full description

Substance use disorder (SUD) is problem among women military Veterans, especially younger ones. The goal of this study was to examine the efficacy a gender-focused model of SUD treatment (A Woman's Path to Recovery, WPR) compared to an evidence-based active comparator that is not gender-specific (12-Step Facilitation, 12SF), in a sample of for women Veterans. The investigators randomized 66 women Veterans, ages 18-65, who were diagnosed with current SUD and used substances in the last 90 days. The treatment phase was 12 weekly individual therapy sessions and all participants could also obtain treatment-as-usual (any other treatments they chose to attend). Assessments were conducted at baseline, end of treatment and 3-month follow up. Sample size was based on power analysis (an effect of .80 at a .05 level of significance). The primary outcome variable was substance use, with various secondary outcomes also studied (e.g., psychosocial functioning, psychiatric symptoms, coping skills, 12-step attendance). Urinalysis / breathalyzer (biological measures) were also included to validate substance use self-report. The investigators hypothesized that participants in the experimental condition (WPR) would have more positive outcomes on both primary and secondary variables compared to those in the comparison condition (12SF). The investigators also hypothesized that WPR patients would increase coping skills more and 12SF would increase 12-step attendance more, relative to the other condition.

Enrollment

66 patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Female Veteran
18-65 years of age
Meet DSM-IV criteria for current SUD with "current" defined as meeting SUD criteria per the DSM-IV and having used a substance within the 90 days prior to intake (to be able to accurately evaluate changes in their substance use from baseline)
Plan to stay in the Boston area for the next 6 months
Have a mailing address and live close enough to come to the hospital once weekly for treatment and/or assessment
Able to complete the Statement of Informed Consent
Willing to participate in all assessments and breathalyzer/urine testing
Willing to provide a release of information such that study staff can contact her other providers as needed regarding any concerns during her participation
Able to obtain medical clearance
Willing to allow us to contact family and/or friends if participant loses contact with us
Literate
Not pregnant or planning to become pregnant

Exclusion criteria

Any acute medical condition that would interfere with the participant's ability to participate in treatment, or would be of such severity as to affect the individual's psychological functioning (e.g., cancer)
Current bipolar I disorder, schizophrenia or other psychotic disorders or mental retardation or organic mental disorder (determined by screening interview)
Any clinical sign that the client is not sufficiently stable to participate in the treatment, such as client's treatment provider indicating that participation in the treatment would be contraindicated
Dangerousness that would present a threat to other staff or other clients (e.g., history of recent assault)
Client is mandated to treatment
Psychopharmacologic treatment that is planned to change or likely to change substantively over the 3-month active treatment phase (with "substantive" defined as any addition of a new medication or major shift in dosage)